Published in Diabetes on October 01, 1992
Increased accumulation of the glycoxidation product N(epsilon)-(carboxymethyl)lysine in human tissues in diabetes and aging. J Clin Invest (1997) 2.48
Maillard reaction products and their relation to complications in insulin-dependent diabetes mellitus. J Clin Invest (1993) 2.03
Immunohistochemical colocalization of glycoxidation products and lipid peroxidation products in diabetic renal glomerular lesions. Implication for glycoxidative stress in the pathogenesis of diabetic nephropathy. J Clin Invest (1997) 1.73
Immunohistochemical localization of advanced glycosylation end products in coronary atheroma and cardiac tissue in diabetes mellitus. Am J Pathol (1993) 1.60
A hydroxyl radical-like species oxidizes cynomolgus monkey artery wall proteins in early diabetic vascular disease. J Clin Invest (2001) 1.36
Non-enzymic glycation of fibrous collagen: reaction products of glucose and ribose. Biochem J (1995) 1.19
The clinical relevance of assessing advanced glycation endproducts accumulation in diabetes. Cardiovasc Diabetol (2008) 1.16
Role of advanced glycation end products in cardiovascular disease. World J Cardiol (2012) 1.13
Diabetes, oxidative stress and physical exercise. J Sports Sci Med (2002) 1.11
Increased collagen-linked pentosidine levels and advanced glycosylation end products in early diabetic nephropathy. J Clin Invest (1993) 1.10
Age-dependent increase in ortho-tyrosine and methionine sulfoxide in human skin collagen is not accelerated in diabetes. Evidence against a generalized increase in oxidative stress in diabetes. J Clin Invest (1997) 1.07
Dietary hyperglycemia, glycemic index and metabolic retinal diseases. Prog Retin Eye Res (2010) 1.06
Elevated AGE-modified ApoB in sera of euglycemic, normolipidemic patients with atherosclerosis: relationship to tissue AGEs. Mol Med (1997) 1.01
Glyco-oxidation and cardiovascular complications in type 2 diabetes: a clinical update. Acta Diabetol (2012) 1.00
A quantitative model of the generation of N(epsilon)-(carboxymethyl)lysine in the Maillard reaction between collagen and glucose. Biochem J (2003) 0.96
Glycation, oxidation, and lipoxidation in the development of the complications of diabetes: a carbonyl stress hypothesis. Diabetes Rev (Alex) (1) 0.95
Aberrant angiogenesis: The gateway to diabetic complications. Indian J Endocrinol Metab (2012) 0.92
The balance of powers: Redox regulation of fibrogenic pathways in kidney injury. Redox Biol (2015) 0.91
Mass spectrometric quantification of amino acid oxidation products identifies oxidative mechanisms of diabetic end-organ damage. Rev Endocr Metab Disord (2008) 0.86
Below the radar: advanced glycation end products that detour "around the side". Is HbA1c not an accurate enough predictor of long term progression and glycaemic control in diabetes? Clin Biochem Rev (2005) 0.86
Flavonoids inhibit the formation of the cross-linking AGE pentosidine in collagen incubated with glucose, according to their structure. Eur J Nutr (2007) 0.84
The role of collagen crosslinks in ageing and diabetes - the good, the bad, and the ugly. Muscles Ligaments Tendons J (2014) 0.82
Advanced glycation end-products reduce collagen molecular sliding to affect collagen fibril damage mechanisms but not stiffness. PLoS One (2014) 0.79
Pathways of the Maillard reaction under physiological conditions. Glycoconj J (2016) 0.78
Extending the spectrum of α-dicarbonyl compounds in vivo. J Biol Chem (2014) 0.78
RAGE and TGF-β1 Cross-Talk Regulate Extracellular Matrix Turnover and Cytokine Synthesis in AGEs Exposed Fibroblast Cells. PLoS One (2016) 0.77
Advanced glycation end products and diabetic retinopathy. J Ocul Biol Dis Infor (2013) 0.77
Consequences of Advanced Glycation End Products Accumulation in Chronic Kidney Disease and Clinical Usefulness of Their Assessment Using a Non-invasive Technique - Skin Autofluorescence. Maedica (Buchar) (2011) 0.77
Biological Effects Induced by Specific Advanced Glycation End Products in the Reconstructed Skin Model of Aging. Biores Open Access (2015) 0.76
Structural alterations of human serum albumin caused by glycative and oxidative stressors revealed by circular dichroism analysis. Int J Mol Sci (2013) 0.76
Protective influence of vitamin E on the antioxidant defence system in the whole blood and liver of normal and alloxan-induced diabetic rats. Indian J Clin Biochem (2008) 0.75
Glycation abolishes the cardioprotective effects of albumin during ex vivo ischemia-reperfusion. Physiol Rep (2017) 0.75
DNA advanced glycation end products (DNA-AGEs) are elevated in urine and tissue in an animal model of type 2 diabetes. Chem Res Toxicol (2017) 0.75
Glycation of human cortical and cancellous bone captures differences in the formation of Maillard reaction products between glucose and ribose. PLoS One (2015) 0.75
Accelerated age-related browning of human collagen in diabetes mellitus. Proc Natl Acad Sci U S A (1984) 4.04
Structure elucidation of a senescence cross-link from human extracellular matrix. Implication of pentoses in the aging process. J Biol Chem (1989) 3.52
Nonenzymatic browning in vivo: possible process for aging of long-lived proteins. Science (1981) 3.25
Relation between complications of type I diabetes mellitus and collagen-linked fluorescence. N Engl J Med (1986) 2.73
Radical AGEing in Alzheimer's disease. Trends Neurosci (1995) 2.32
Diabetic cataract formation: potential role of glycosylation of lens crystallins. Proc Natl Acad Sci U S A (1978) 2.14
Advanced Maillard reaction end products are associated with Alzheimer disease pathology. Proc Natl Acad Sci U S A (1994) 1.91
miR-145 participates with TP53 in a death-promoting regulatory loop and targets estrogen receptor-alpha in human breast cancer cells. Cell Death Differ (2009) 1.82
Mechanism of protein modification by glyoxal and glycolaldehyde, reactive intermediates of the Maillard reaction. J Biol Chem (1995) 1.76
Mechanism of formation of the Maillard protein cross-link pentosidine. Glucose, fructose, and ascorbate as pentosidine precursors. J Biol Chem (1991) 1.74
Immunohistochemical colocalization of glycoxidation products and lipid peroxidation products in diabetic renal glomerular lesions. Implication for glycoxidative stress in the pathogenesis of diabetic nephropathy. J Clin Invest (1997) 1.73
Preoperative risk factors for postoperative delirium (POD) after urological surgery in the elderly. Arch Gerontol Geriatr (2010) 1.67
End-stage renal disease and diabetes catalyze the formation of a pentose-derived crosslink from aging human collagen. J Clin Invest (1990) 1.66
Clinical and immunological risk factors associated with Haemophilus influenzae type b conjugate vaccine failure in childhood. Clin Infect Dis (2000) 1.65
High correlation between pentosidine protein crosslinks and pigmentation implicates ascorbate oxidation in human lens senescence and cataractogenesis. Proc Natl Acad Sci U S A (1991) 1.63
Collagen aging in vitro by nonenzymatic glycosylation and browning. Diabetes (1984) 1.55
Aging of proteins: immunological detection of a glucose-derived pyrrole formed during maillard reaction in vivo. J Biol Chem (1989) 1.49
Porphyrin abnormalities in acquired immunodeficiency syndrome. Arch Dermatol (1996) 1.44
Evaluation of diagnostic reliability of DCA 2000 for rapid and simple monitoring of HbA1c. Acta Diabetol (2000) 1.37
Non-type b Haemophilus influenzae disease: clinical and epidemiologic characteristics in the Haemophilus influenzae type b vaccine era. Pediatr Infect Dis J (2001) 1.35
Maillard reaction-mediated molecular damage to extracellular matrix and other tissue proteins in diabetes, aging, and uremia. Diabetes (1992) 1.32
Glycation of skin collagen in type I diabetes mellitus. Correlation with long-term complications. Diabetes (1986) 1.27
Detection of D-glucose-derived pyrrole compounds during Maillard reaction under physiological conditions. Carbohydr Res (1987) 1.23
A radioimmunoassay for the quantitative evaluation of anti-human acetylcholine receptor antibodies in myasthenia gravis. Clin Exp Immunol (1977) 1.23
The chemistry of the Maillard reaction under physiological conditions: a review. Prog Clin Biol Res (1989) 1.23
Plasma levels of amyloid beta-protein 42 are increased in women with mild cognitive impairment. Neurology (2004) 1.23
Structure and mechanism of formation of human lens fluorophore LM-1. Relationship to vesperlysine A and the advanced Maillard reaction in aging, diabetes, and cataractogenesis. J Biol Chem (1999) 1.22
Involvement of hydrogen peroxide in collagen cross-linking by high glucose in vitro and in vivo. J Biol Chem (1996) 1.20
Chromatographic quantitation of plasma and erythrocyte pentosidine in diabetic and uremic subjects. Diabetes (1992) 1.20
Isolation, purification and partial characterization of novel fluorophores from aging human insoluble collagen-rich tissue. Connect Tissue Res (1989) 1.20
Behavioural risk factors among young adults in small areas with high mortality versus those in low-mortality areas. Int J Epidemiol (1991) 1.18
Boston naming test short forms: a comparison of previous forms with new item response theory based forms. J Clin Exp Neuropsychol (2004) 1.16
AGEs, rather than hyperglycemia, are responsible for microvascular complications in diabetes: a "glycoxidation-centric" point of view. Nutr Metab Cardiovasc Dis (2013) 1.15
Oxidative stress induces increase in intracellular amyloid beta-protein production and selective activation of betaI and betaII PKCs in NT2 cells. Biochem Biophys Res Commun (2000) 1.14
Isolation, purification, and characterization of amadoriase isoenzymes (fructosyl amine-oxygen oxidoreductase EC 1.5.3) from Aspergillus sp. J Biol Chem (1997) 1.14
Non-enzymatic glycosylation and browning of proteins in diabetes. Clin Endocrinol Metab (1982) 1.13
Longevity and the genetic determination of collagen glycoxidation kinetics in mammalian senescence. Proc Natl Acad Sci U S A (1996) 1.13
Mechanisms for the formation of glycoxidation products in end-stage renal disease. Kidney Int (2000) 1.11
Nonenzymatic glycosylation, sulfhydryl oxidation, and aggregation of lens proteins in experimental sugar cataracts. J Exp Med (1979) 1.09
Cloning of amadoriase I isoenzyme from Aspergillus sp.: evidence of FAD covalently linked to Cys342. Biochemistry (2000) 1.09
Role of nonenzymatic glycosylation in the development of the sequelae of diabetes mellitus. Metabolism (1979) 1.09
Advanced Maillard reaction end products, free radicals, and protein oxidation in Alzheimer's disease. Ann N Y Acad Sci (1994) 1.07
Detection of nonenzymatic browning products in the human lens. Biochim Biophys Acta (1983) 1.06
Clinical and socio-economic correlates of quality of life and treatment satisfaction in patients with type 2 diabetes. Nutr Metab Cardiovasc Dis (2008) 1.05
Advanced glycation end products in human penis: elevation in diabetic tissue, site of deposition, and possible effect through iNOS or eNOS. Urology (1997) 1.01
Longitudinal determination of skin collagen glycation and glycoxidation rates predicts early death in C57BL/6NNIA mice. FASEB J (2000) 1.00
Pentosidine: a molecular marker for the cumulative damage to proteins in diabetes, aging, and uremia. Diabetes Metab Rev (1991) 1.00
Molecular cloning and expression of amadoriase isoenzyme (fructosyl amine:oxygen oxidoreductase, EC 1.5.3) from Aspergillus fumigatus. J Biol Chem (1997) 1.00
Quality of life in pregnancy and post-partum: a study in diabetic patients. Qual Life Res (2011) 0.99
Antepartum and early postpartum predictors of type 2 diabetes development in women with gestational diabetes mellitus. Diabetes Metab (2001) 0.99
Levuglandin E2-protein adducts in human plasma and vasculature. Chem Res Toxicol (1997) 0.98
Transition metal-catalyzed oxidation of ascorbate in human cataract extracts: possible role of advanced glycation end products. Invest Ophthalmol Vis Sci (2000) 0.97
Identification of pentosidine as a native structure for advanced glycation end products in beta-2-microglobulin-containing amyloid fibrils in patients with dialysis-related amyloidosis. Proc Natl Acad Sci U S A (1996) 0.95
Use of premixed insulin among the elderly. Reduction of errors in patient preparation of mixtures. Diabetes Care (1992) 0.95
Formation and stability of pyrrole adducts in the reaction of levuglandin E2 with proteins. Chem Res Toxicol (1995) 0.95
Age-related normalization of the browning rate of collagen in diabetic subjects without retinopathy. J Clin Invest (1986) 0.94
Increased expression of tissue plasminogen activator and its inhibitor and reduced fibrinolytic potential of human endothelial cells cultured in elevated glucose. Diabetes (1992) 0.93
Isolation, purification, and characterization of an Amadori product binding protein from a Pseudomonas sp. soil strain. J Biol Chem (1994) 0.92
Oxidative posttranslational modifications in Alzheimer disease. A possible pathogenic role in the formation of senile plaques and neurofibrillary tangles. Mol Chem Neuropathol (1997) 0.92
Differential effects of type 2 (non-insulin-dependent) diabetes mellitus on pentosidine formation in skin and glomerular basement membrane. Diabetologia (1993) 0.91
Glucagon-like peptide-1 counteracts the detrimental effects of Advanced Glycation End-Products in the pancreatic beta cell line HIT-T 15. Biochem Biophys Res Commun (2010) 0.91
Mass spectrometric study of in vivo production of advanced glycation end-products/peptides. J Mass Spectrom (2005) 0.90
Advanced glycation end-products affect transcription factors regulating insulin gene expression. Biochem Biophys Res Commun (2010) 0.90
Early and advanced glycosylation end products. Kinetics of formation and clearance in peritoneal dialysis. J Clin Invest (1996) 0.90
Isolation and characterization of a blue fluorophore from human eye lens crystallins: in vitro formation from Maillard reaction with ascorbate and ribose. Biochim Biophys Acta (1992) 0.90
Novel degradation pathway of glycated amino acids into free fructosamine by a Pseudomonas sp. soil strain extract. J Biol Chem (1995) 0.90
The epidemiology of domestic injurious falls in a community dwelling elderly population: an outgrowing economic burden. Eur J Public Health (2009) 0.89
Effect of ethanol, acetaldehyde, and acetate on insulin and glucagon secretion in the perfused rat pancreas. Diabetes (1981) 0.89
Influence of dialysis modality on plasma and tissue concentrations of pentosidine in patients with end-stage renal disease. Am J Kidney Dis (1995) 0.89
Plasma lipoproteins, apoproteins and cardiovascular disease in type 2 diabetic patients. A nine-year follow-up study. Nutr Metab Cardiovasc Dis (2003) 0.88
Protein aging by carboxymethylation of lysines generates sites for divalent metal and redox active copper binding: relevance to diseases of glycoxidative stress. Biochem Biophys Res Commun (1999) 0.88
Preprandial combination of lispro and NPH insulin improves overall blood glucose control in type 1 diabetic patients: a multicenter randomized crossover trial. Nutr Metab Cardiovasc Dis (2001) 0.88
Relationship between glyco-oxidation, antioxidant status and microalbuminuria in type 2 diabetic patients. Diabetologia (2009) 0.88
Immunological evidence for increased oxidative stress in diabetic rats. Diabetologia (1998) 0.88
Ten-year survival of Down syndrome births. Int J Epidemiol (1997) 0.87
Studies of renal injury III: lipid-induced nephropathy in type II diabetes. Kidney Int (2000) 0.87
Protein modification by the degradation products of ascorbate: formation of a novel pyrrole from the Maillard reaction of L-threose with proteins. Biochim Biophys Acta (1995) 0.87
What did we learn about leadership in medical education? Effecting institutional change through the Interdisciplinary Generalist Curriculum Project. Acad Med (2001) 0.87
Monocyte/macrophage response to beta 2-microglobulin modified with advanced glycation end products. Kidney Int (1996) 0.86
Age-related association of tail tendon break time with tissue pentosidine in DBA/2 vs C57BL/6 mice: the effect of dietary restriction. J Gerontol A Biol Sci Med Sci (1997) 0.86
Maillard reactions involving proteins and carbohydrates in vivo: relevance to diabetes mellitus and aging. Prog Food Nutr Sci (1981) 0.86
Purification and characterization of a membrane-bound deglycating enzyme (1-deoxyfructosyl alkyl amino acid oxidase, EC 1.5.3) from a Pseudomonas sp. soil strain. J Biol Chem (1996) 0.86
Methylglyoxal-bovine serum albumin stimulates tumor necrosis factor alpha secretion in RAW 264.7 cells through activation of mitogen-activating protein kinase, nuclear factor kappaB and intracellular reactive oxygen species formation. Arch Biochem Biophys (2003) 0.85
A comparison between MALDI-MS and CE-MS data for biomarker assessment in chronic kidney diseases. J Proteomics (2012) 0.84
A new surgical approach to fractures of the lateral tibial plateau. J Bone Joint Surg Am (1984) 0.84
Progressive deterioration of beta-cell function in nonobese type 2 diabetic subjects. Postprandial plasma C-peptide level is an indication of insulin dependency. Diabetes Metab (1996) 0.83
A syndrome of molybdenosis, copper deficiency, and type 2 diabetes in the moose population of south-west Sweden. Sci Total Environ (2000) 0.83
Early AGEing and Alzheimer's. Nature (1995) 0.83
Effect of lercanidipine compared with ramipril on albumin excretion rate in hypertensive Type 2 diabetic patients with microalbuminuria: DIAL study (diabete, ipertensione, albuminuria, lercanidipina). Diabetes Nutr Metab (2004) 0.83
Suppression of pentosidine formation in galactosemic rat lens by an inhibitor of aldose reductase. Diabetes (1994) 0.83
Malondialdehyde (MDA) level in diabetic subjects. Relationship with blood glucose and glycosylated hemoglobin. Biomed Pharmacother (1991) 0.83
Chromatographic evidence for pyrraline formation during protein glycation in vitro and in vivo. Biochim Biophys Acta (1995) 0.83
Effects of kidney or kidney-pancreas transplantation on plasma pentosidine. Kidney Int (1993) 0.82
ELISA of pentosidine, an advanced glycation end product, in biological specimens. Clin Chem (1994) 0.82
Lipoprotein abnormalities in well-treated type II diabetic patients. Diabetes Care (1993) 0.82